NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2025
Back to search
Official data from USPTO
CONNECT COLLABORATE ACCELERATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONNECT COLLABORATE ACCELERATE
ST13
US500000079273882Class
42
Filing
79273882
Registration
6202711
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
11/30/2025
Trademark type
Word
Nice classes
42
Filing date
05/16/2019
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Sheffield, GB
Examiner
MEYERS,MORGAN LAURA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BioPhorum Operations Group Limited
Representatives
Angela P. Doughty Ward and Smith, P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Compiling data for research purpose in the field of medical science and medical consultancy; product development consultation; pharmaceutical research and development; consultancy on pharmaceutical product developmentbiopharmaceutical product developmentbiotechnology product developmentmedical device product development; technical research in the field of pharmaceutical studies; technical research in the field of biopharmaceuticalsbiotechnologymedical devices and life science studies; technical consulting in the field of pharmaceutical studies; consultancy in the field of pharmaceutical research; testinginspectionresearchdevelopment of pharmaceutical preparations; research on the subject of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; providing medical and scientific research information in the field of biopharmaceuticalsbiotechnologymedical devices and life sciences; Developing quality control standards for pharmaceuticalbiopharmaceutical and medical device manufacturing; Consultancy services in relation to developing quality control standards for pharmaceuticalbiopharmaceutical and medical device manufacturing; Quality management servicesquality evaluation and analysisquality assurancequality controlin the field of for pharmaceuticalsbiopharmaceuticalsbiotechnologymedical devices; Consultancy services in relation to quality evaluation and analysisquality assurancequality controlin the field of for pharmaceuticalsbiopharmaceuticalsbiotechnologymedical devices; Advisory in the field of quality control of manufactured goods; scientific research in the field of healthcaremedical technologymedical deviceslife sciencespharmaceuticalbiopharmaceuticalbiotechnology; providing consultation in the field of sciencehealthcaremedical technologymedical deviceslife sciencespharmaceuticalbiopharmaceuticalbiotechnology; Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcarepharmaceuticalsbiopharmaceuticalsmedical devices
Publications
History of USPTO decisions and trademark events.
25 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/24/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/27/2021
FIMP
FINAL DISPOSITION PROCESSED
02/27/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
ALIE
ASSIGNED TO LIE
08/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2020
RFNT
REFUSAL PROCESSED BY IB
02/01/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2020
RFRR
REFUSAL PROCESSED BY MPU
01/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/18/2019
CNRT
NON-FINAL ACTION WRITTEN
12/17/2019
DOCK
ASSIGNED TO EXAMINER
12/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/16/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/14/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2019
Continuous trademark protection
Get notified about every new filing that threatens CONNECT COLLABORATE ACCELERATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.